Development and characterization of novel clinical grade neonatal porcine bone marrow‐derived mesenchymal stem cells
- 15 February 2019
- journal article
- research article
- Published by Wiley in Xenotransplantation
- Vol. 26 (3) , e12501
Abstract
Due to recent advances in research on mesenchymal stem cells (MSCs), MSCs are expected to be used in various clinical applications. However, securing adequate cadaveric donors and safety of living donors are major issues. To solve such issues, we have examined to develop clinical grade neonatal porcine bone marrow‐derived MSCs (npBM‐MSCs). Clinical grade neonatal porcine bone marrow cells were collected, frozen, and sent to our laboratory by air. The npBM‐MSCs were isolated from thawed bone marrow cells, then frozen. The thawed npBM‐MSCs were examined for CD markers and differentiated into chondrocytes, osteocytes, and adipocytes. They were compared with human bone marrow‐derived MSCs (hBM‐MSCs) for growth rate and size. To assess the robustness of proliferation, we compared culture medium with or without gelatin. The npBM‐MSCs expressed positive MSC markers CD29, CD44, and CD90 and were differentiated into chondrocytes, osteocytes, and adipocytes. The doubling time of npBM‐MSCs was significantly shorter than that of hBM‐MSCs (17.3 ± 0.8 vs 62.0 ± 19.6 hours, P < 0.01). The size of npBM‐MSCs was also significantly smaller than that of hBM‐MSCs (13.1 ± 0.3 vs 17.5 ± 0.4 μm, P < 0.001). The npBM‐MSCs showed similar proliferation characters irrespective of with or without gelatin coating. The npBM‐MSCs secreted VEGF‐A, VEGF‐C, and TGF‐β1. We have established npBM‐MSCs which show super‐rapid growth, small size, and robust proliferation profile. The np‐MSCs might be able to solve the donor issues for MSC therapy.Keywords
This publication has 19 references indexed in Scilit:
- Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 DiabetesEBioMedicine, 2016
- A Simple, Rapid, and Efficient Method for Isolating Mesenchymal Stem Cells from the Entire Umbilical CordCell Transplantation, 2016
- Current status and future of clinical islet xenotransplantationJournal of Diabetes, 2016
- Isolation of Pig Bone Marrow-Derived Mesenchymal Stem Cells2016
- Clinical-scale expansion of mesenchymal stromal cells: a large banking experienceJournal of Translational Medicine, 2016
- First Approval of Regenerative Medical Products under the PMD Act in JapanCell Stem Cell, 2016
- Regulatory aspects of clinical xenotransplantationInternational Journal of Surgery, 2015
- Characteristics and Properties of Mesenchymal Stem Cells Derived from Microfragmented Adipose TissueCell Transplantation, 2015
- Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantationJournal of Cellular and Molecular Medicine, 2012
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006